Biotech Takeover Targets Wall Street Eyes After Apogee Deal
AbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
This guide highlights why Dow Jones Differs From Sp 500, focusing on composition and calculation differences. Understand which index suits your analysis.
19,351 articlesAbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
House Democrats unveiled a pair of bills aimed at banning event contracts on Polymarket US and other platforms. The m...
NAR’s board maintained 2027 dues at $156 per member and kicked a proposed ethics Standard of Practice back to committ...
An ETF-based approach blends residential and mortgage REITs to generate passive income without property management. A...
A new NVIDIA-backed player has stepped into the high-growth AI photonics space, challenging traditional data-center b...
Roughly 1 in 5 adults suffer from chronic pain, rising with age. This report outlines 12 non-drug therapies and how f...
Cumberland, Fluid, and SwissBorg join Hashi ahead of Sui's July testnet launch, expanding Bitcoin-backed DeFi rails a...
Nvidia has committed $2 billion to Nebius Group, accelerating Nebius’s role in the neocloud era. The move includes ea...
A fresh look at ProShares UltraPro QQQ reveals that while the fund lists a 0.82% annual expense, the real erosion com...
As labor markets stay tight, businesses are learning that unlocking discretionary effort hinges on culture and frontl...
Meta Platforms is advancing Arena, a stand-alone prediction markets app that would start with non-cash points and cou...
As AI stocks cool, a rotation toward durable, revenue-generating assets accelerates. A new wheel technology startup i...